1.430USD+9.58%Mkt Cap: 319.71M USDP/E: —Last update: 2026-06-01
Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of ana…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap319.71M USD
Enterprise Value306.59M USD
Revenue (TTM)2.02M USD
Gross Profit-7.66M USD
Net Income (TTM)-40.83M USD
Revenue/Share0.0120 USD
Last Price1.430 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees184
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.41
PEG—
EV/EBITDA-2.92
EV/Revenue152.08
P/S143.17
P/B81.25
EPS (TTM)-0.63
EPS (Forward)-0.29
52W Range
0.547037% of range2.930
52W High2.930 USD
52W Low0.5470 USD
Profitability
Gross Margin-376.05%
Oper. Margin-5704.04%
EBITDA Margin0.00%
Profit Margin-2003.58%
ROE-1313.38%
ROA-35.09%
Growth
Revenue Growth-4.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-105.04M USD
CapEx (TTM)884.00K USD
FCF Margin-3214.61%
FCF Yield-20.27%
Net Debt17.96M USD
Net Debt/EBITDA-0.17
Balance Sheet
Debt/Equity20.86
Current Ratio3.93
Quick Ratio3.02
Book Value/Sh0.0160 USD
Cash/Share0.2190 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Target (Mean)1.667 USD
Target Range1.000 USD – 3.000 USD
# Analysts6
Ownership
Shares Out.222.02M
Float190.79M
Insiders9.12%
Institutions26.93%
Short Interest
Short Ratio6.7d
Short % Float18.68%
Short % Out.18.54%
Shares Short41.16M
Short (prev mo.)44.84M
Technical
SMA 500.8297 (+72.3%)
SMA 2001.221 (+17.1%)
Beta2.31
S&P 52W Chg27.94%
Avg Vol (30d)6.40M
Avg Vol (10d)6.75M
Technical Indicators
RSI (14)68.7
MACD0.0933
MACD Signal0.0629
MACD Hist.+0.0304
BB Upper1.270 USD
BB Middle1.014 USD
BB Lower0.7585 USD
BB Width50.41%
ATR (14)0.1130 USD
Vol Ratio (20d)1.14x